Immune globulin subcutaneous and Moxetumomab pasudotox
Determining the interaction of Immune globulin subcutaneous and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: immune globulin subcutaneous
Brand name: Cutaquig, Cuvitru, Hizentra, Vivaglobin, Xembify
Synonyms: Immune globulin (subcutaneous)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Immune globulin subcutaneous-Moxetumomab Pasudotox-tdfk
- Immune globulin subcutaneous-Moxetumomab pasudotox-tdfk Intravenous
- Immune globulin subcutaneous-Moxifloxacin
- Immune globulin subcutaneous-Moxifloxacin (Systemic)
- Immune globulin subcutaneous-Moxifloxacin Hydrochloride
- Immune globulin subcutaneous-Moxifloxacin Injection
- Moxetumomab pasudotox-Immune globulin-ifas Intravenous
- Moxetumomab pasudotox-Imodium
- Moxetumomab pasudotox-Imodium A-D
- Moxetumomab pasudotox-Imodium A-D EZ Chews
- Moxetumomab pasudotox-Imodium A-D New Formula
- Moxetumomab pasudotox-Imodium Multi-Symptom Relief